Your browser doesn't support javascript.
loading
Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients.
Mercadante, Sebastiano; Adile, Claudio; Lanzetta, Gaetano; Mystakidou, Kyriaki; Maltoni, Marco; Guilherme Soares, Luiz; De Santis, Stefano; Ferrera, Patrizia; Valenti, Marco; Rosati, Marta; Rossi, Romina; Cortegiani, Andrea; Masedu, Francesco; Marinangeli, Franco; Aielli, Federica.
Afiliación
  • Mercadante S; Pain Relief & Supportive Care, La Maddalena Cancer Center, Palermo, Italy terapiadeldolore@lamaddalenanet.it 03sebelle@gmail.com.
  • Adile C; Pain Relief & Supportive Care, La Maddalena Cancer Center, Palermo, Italy.
  • Lanzetta G; Medical Oncology Unit, IRCCS Neuromed, Pozzilli, Italy.
  • Mystakidou K; Medical Oncology Unit, Italian Neuro-Traumatology Institute, Grottaferrata, Italy.
  • Maltoni M; Pain Relief and Palliative Care Unit, Department of Radiology, Areteion Hospital, National & Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Guilherme Soares L; Palliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
  • De Santis S; Post-Acute Care Services and Palliative Care Program, Hospital Placi, Niterói, Rio de Janeiro, Brazil.
  • Ferrera P; Palliative Care and Oncologic Pain Service, S. Camillo-Forlanini Hospital, Rome, Italy.
  • Valenti M; Pain Relief & Supportive Care, La Maddalena Cancer Center, Palermo, Italy.
  • Rosati M; Department of Biotechnological and Applied Clinical Sciences, Section of Clinical Epidemiology and Environmental Medicine.
  • Rossi R; Palliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
  • Cortegiani A; Palliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
  • Masedu F; Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy.
  • Marinangeli F; Department of Biotechnological and Applied Clinical Sciences, Section of Clinical Epidemiology and Environmental Medicine.
  • Aielli F; Anesthesiology and Pain Medicine, Department of Life Health and Environmental Sciences, University of L'Aquila, Italy.
Oncologist ; 24(2): 239-246, 2019 02.
Article en En | MEDLINE | ID: mdl-29769382
ABSTRACT

BACKGROUND:

The aim of this study was to assess the patients' global impression (PGI) after symptom management, as well as the achievement of personalized symptom goals (PSG). The secondary outcome was to assess related factors. SUBJECTS, MATERIALS, AND

METHODS:

Advanced cancer patients admitted to palliative care units rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission and then after 1 week. For each symptom, patient-reported PGI and PSG, as well as the rate of PSG response, were evaluated.

RESULTS:

Eight hundred seventy-six patients were taken into consideration for this study. A mean of 1.71-2.16 points was necessary to perceive a bit better improvement of symptom intensity. Most patients had a PSG of ≤3. A statistically significant number of patients achieved their PSG after starting palliative care. Patients with high intensity of ESAS items at admission achieved a more favorable PGI response. In the multivariate analysis, symptom intensity and PSG were the most frequent factors independently associated to a best PGI, whereas high levels of Karnofsky had a lower odd ratio.

CONCLUSION:

PSG and PGI seem to be relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. IMPLICATIONS FOR PRACTICE Personalized symptom goals and global impression of change are relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article